Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 1960-1965

  Pinney, Sara E ^a,b   Oliver Krasinski, Jennifer ^b   Ernst, Linda ^c   Hughes, Nkecha ^a   Patel, Puja ^a   Stoffers, Doris A ^b   Russo, Pierre ^a   De León, Diva D ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ELASTASE; GLUCOSE; NEUROGENIN 3;

CASE REPORT; CONFERENCE PAPER; CONGENITAL MALABSORPTIVE DIARRHEA; DIABETES MELLITUS; DIARRHEA; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; NEUROG3 GENE; NEWBORN DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL INTESTINE; WESTERN BLOTTING;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIABETES MELLITUS; DIARRHEA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTESTINE, SMALL; MUTATION; NERVE TISSUE PROTEINS;

EID: 79960108667     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0029     Document Type: Conference Paper

References (29)

1. Oliver-Krasinski JM, Stoffers DA 2008 On the origin of the β cell. Genes Dev 22:1998-2021
2. Gradwohl G, Dierich A, LeMeur M, Guillemot F 2000 neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97:1607-1611 (Pubitemid 30118489)
3. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA 2004 Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development 131:165-179 (Pubitemid 38111424)
4. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, Guillemot F, Jensen J, Kedinger M, Gradwohl G 2002 Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21:6338-6347 (Pubitemid 35448412)
5. Lee CS, Perreault N, Brestelli JE, Kaestner KH 2002 Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev 16:1488-1497 (Pubitemid 34686330)
6. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY 2001 Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294:2155-2158 (Pubitemid 33150670)
7. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD 2000 Control of endodermal endocrine development by Hes-1. Nat Genet 24:36-44 (Pubitemid 30041417)
8. Wang J, Cortina G, Wu SV, Tran R, Cho JH, Tsai MJ, Bailey TJ, Jamrich M, Ament ME, Treem WR, Hill ID, Vargas JH, Gershman G, Farmer DG, Reyen L, Martín MG 2006 Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med 355:270-280 (Pubitemid 44079341)
9. López-Díaz L, Jain RN, Keeley TM, Van Dussen KL, Brunkan CS, Gumucio DL, Samuelson LC 2007 Intestinal neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev Biol 309:298-305 (Pubitemid 47361113)
10. Bjerknes M, Cheng H 2006 Neurogenin 3 and the enteroendocrine cell lineage in the adult mouse small intestinal epithelium. Dev Biol 300:722-735 (Pubitemid 44914135)
11. Schonhoff SE, Giel-Moloney M, Leiter AB 2004 Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol 270:443-454 (Pubitemid 38748564)
12. Mellitzer G, Beucher A, Lobstein V, Michel P, Robine S, Kedinger M, Gradwohl G 2010 Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival. J Clin Invest 120:1708-1721
13. Schwitzgebel VM, Scheel DW, Conners JR, Kalamaras J, Lee JE, Anderson DJ, Sussel L, Johnson JD, German MS 2000 Expression of neurogenin 3 reveals an islet cell precursor population in the pancreas. Development 127:3533-3542
14. Jensen J, Heller RS, Funder-Nielsen T, Pedersen EE, Lindsell C, Weinmaster G, Madsen OD, Serup P 2000 Independent development of pancreatic α- and β-cells from neurogenin 3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 49:163-176 (Pubitemid 30070993)
15. Gu G, Dubauskaite J, Melton DA 2002 Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129:2447-2457 (Pubitemid 34863851)
16. Huang HP, Liu M, El-Hodiri HM, Chu K, Jamrich M, Tsai MJ 2000 Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol Cell Biol 20:3292-3307 (Pubitemid 30215041)
17. Smith SB, Gasa R, Watada H, Wang J, Griffen SC, German MS 2003 Neurogenin 3 and hepatic nuclear factor 1 cooperate in activating pancreatic expression of Pax4. J Biol Chem 278:38254-38259 (Pubitemid 37221715)
18. Watada H, Scheel DW, Leung J, German MS 2003 Distinct gene expression programs function in progenitor and mature islet cells. J Biol Chem 278:17130-17140 (Pubitemid 36799591)
19. Smith SB, Watada H, German MS 2004 Neurogenin 3 activates the islet differentiation program while repressing its own expression. Mol Endocrinol 18:142-149 (Pubitemid 38073160)
20. Mellitzer G, Bonné S, Luco RF, Van De Casteele M, Lenne-Samuel N, Collombat P, Mansouri A, Lee J, Lan M, Pipeleers D, Nielsen FC, Ferrer J, Gradwohl G, Heimberg H 2006 IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas. EMBO J 25:1344-1352
21. Smith SB, Qu HQ, Taleb N, Kishimoto NY, Scheel DW, Lu Y, Patch AM, Grabs R, Wang J, Lynn FC, Miyatsuka T, Mitchell J, Seerke R, Désir J, Eijnden SV, Abramowicz M, Kacet N, Weill J, Renard ME, Gentile M, Hansen I, Dewar K, Hattersley AT, Wang R, Wilson ME, Johnson JD, Polychronakos C, German MS 2010 Rfx6 directs islet formation and insulin production in mice and humans. Nature 463:775-780
22. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ 1997 Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 11:2323-2334 (Pubitemid 27408530)
23. Jackson AE, Cassell PG, North BV, Vijayaraghavan S, Gelding SV, Ramachandran A, Snehalatha C, Hitman GA 2004 Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-l alpha genes contribute to glucose intolerance in a South Indian population. Diabetes 53:2122-2125 (Pubitemid 38970764)
24. Li J, Bergmann A, Reimann M, Schulze J, Bornstein SR, Schwarz PE 2008 Genetic variation of neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes. Exp Clin Endocrinol Diabetes 116:178-183 (Pubitemid 351518538)
25. Milord E, Gragnoli C 2006 NEUROG3 variants and type 2 diabetes in Italians Minerva Med 97:373-378
26. Jensen JN, Hansen L, Ekstrom CT, Pociot F, Nerup J, Hansen T, Pedersen O 2001 Polymorphisms in the neurogenin 3 gene (NEUROG) and their relation to altered insulin secretion and diabetes in the Danish Caucasian population. Diabetologia 44:123-126 (Pubitemid 32141894)
27. Kim SH, Warram JH, Krolewski AS, Doria A 2001 Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes. J Clin Endocrinol Metab 86:2320-2322 (Pubitemid 32472958)
28. del Bosque-Plata L, Lin J, Horikawa Y, Schwarz PE, Cox NJ, Iwasaki N, Ogata M, Iwamoto Y, German MS, Bell GI 2001 Mutations in the coding region of the neurogenin 3 gene (NEUROG3) are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes 50:694-696 (Pubitemid 32195238)
29. Okada T, Tobe K, Hara K, Yasuda K, Kawaguchi Y, Ikegami H, Ito C, Kadowaki T 2001 Variants of neurogenin 3 gene are not associated with Type II diabetes in Japanese subjects. Diabetologia 44:241-244 (Pubitemid 32156210)